Aldebaran Therapeutics

Private

Waltham, MassachusettsHealthcare & Life Scienceshttps://aldebarantx.com/

Last Round

Accelerator

Feb 9, 2022

Total Funding Raised

$800,000

Company Overview

Aldebaran Therapeutics is a biotechnology company that leverages human genetics and antisense oligonucleotide technology to develop precision ocular medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antisense oligonucleotideASOgenetic medicineocular diseaseprecision medicinebiotechdrug discoveryophthalmologygene therapypre-clinical biotechventure studiotherapeutic platformbiotech startupasset-centric biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aldebaran Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Aldebaran Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aldebaran Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Feb 9, 2022

View all Funding Rounds

Aldebaran Therapeutics Investors

Notable investors and investment history

Aldebaran Therapeutics investors
Investor	Rounds
82VS	Accelerator

View all Investors

Aldebaran Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aldebaran Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aldebaran Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts

Employee Range5

Year Founded2022

Last FundingFeb 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.